A new frontier for brain cancer treatment

A new nanocell drug may change the way doctors target glioblastoma, a deadly form of brain cancer that’s especially tough to treat. Dr. John Boockvar, vice chair of neurosurgery at Lenox Hill Hospital, explains the cancer-fighting mechanism behind EnGeneIC Dream Vector (EDV) and how it works within the brain.

Get the latest health news

Keep up-to-date on breaking health news with insights from our experts and developments from around the health system.